NASDAQ
Neuren Pharmaceuticals Limited (NURPF) has a current ratio of 76.60x as of Tuesday, May 26, 2026. This represents a 239.91% increase compared to its 12-month average of 22.54x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.